Cellebrite DI (CLBT) Non Operating Investment Income (2022 - 2025)

Cellebrite DI's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at $16000.0 for Q4 2025.

• On a quarterly basis, Non Operating Investment Income rose 103.89% year-over-year to $16000.0 in Q4 2025; TTM through Dec 2025 was $3.1 million, a 2617.7% increase from a year earlier, with the FY2025 full-year figure at $317000.0, up 180.53% from the prior year.
• Non Operating Investment Income declined to $16000.0 in Q4 2025 per CLBT's latest filing, from $198000.0 in the prior quarter.
• Across five years, Non Operating Investment Income topped out at $2.8 million in Q2 2025 and bottomed at -$411000.0 in Q4 2024.
• The 4-year median for Non Operating Investment Income is $30000.0 (2022), against an average of $199250.0.
• Across the five-year window, Non Operating Investment Income sank 240.27% in 2024 and soared 2893.0% in 2025, its largest moves.
• Year by year, Non Operating Investment Income stood at $44000.0 in 2022, then jumped by 565.91% to $293000.0 in 2023, then sank by 240.27% to -$411000.0 in 2024, then surged by 103.89% to $16000.0 in 2025.
• Per Business Quant, the three latest CLBT Non Operating Investment Income figures stand at $16000.0 (Q4 2025), $198000.0 (Q3 2025), and $2.8 million (Q2 2025).